Geron gets ruling over patent case in Europe

09/4/2007 | American City Business Journals

The European Patent Agency supported an earlier ruling that narrows the claims of a patent filed by Pharmexa in 2003. Geron Corp. said the Pharmexa patent, which covers telomerase peptides and nucleic acids for cancer treatment use, was too broad and covered material patented by Geron.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care